Skip to main content
Clinical Trials/ACTRN12618000102279
ACTRN12618000102279Completed未知

Does probiotic treatment affect gut dysbiosis and cognitive outcomes in people with Huntington's Disease?

Monash University0 sites84 target enrollmentStarted: January 23, 2018Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
84

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 70 Years (—)
Sex
All

Inclusion Criteria

  • Healthy control and Huntington's disease participants aged 18-70 will be eligible barring they do not violate any of the exclusion criteria.

Exclusion Criteria

  • Exclusion criteria for all participants includes; diagnosis of any other major neurological disorder, traumatic brain injury, drug or alcohol dependency (in the last 3 months), recent diagnosis of major depression or psychosis, consumption of oral antibiotics (in the past 6 months), high daily consumption of probiotic or fermented foods (foods preserved in high amounts of bacteria) within six weeks prior to the study. Further exclusion includes hospitalised patients with a central venous catheter, people with allergies to yeast, people with a diagnosis of Irritable Bowel Syndrome, Celiac's disease or Crohn's disease and people who are severely ill and/or immunocompromised.

Investigators

Similar Trials